Clinician's Roundtable

Host: Leslie P. Lundt, MD Guest: Daniel Carlat, MD Dr. Daniel Carlat has written in a New York Times article called, “Dr. Drug Rep”, that allowing pharmaceutical companies to sponsor medical education leads to many bad things, including biased education, corrupt physicians, and, ultimately, harm to our patients. Host Dr. Leslie Lundt listens to what he has to say.

Host: Leslie P. Lundt, MD Guest: Kevin Antshel, PhD Does the diagnosis of ADHD qualify an adult for special accommodations under the ADA? ADHD expert Dr. Kevin Antshel explains how the process works to host Dr. Leslie Lundt.

Host: Leslie P. Lundt, MD Guest: Kevin Antshel, PhD Traditional wisdom says that people with ADHD have lower IQs. Is it possible to have ADHD and a high IQ? Syracuse University psychologist Dr. Kevin Antshel joins host Dr. Leslie Lundt to discuss twice exceptional children.

Host: Larry Kaskel, MD Guest: Ezra Cohen, MD Rapamycin has potential anti-cancer activity but poor oral bioavailability. Grapefruit Juice increases the bioavailability of many drugs. In this segment, Dr. Ezra Cohen shares his research in which he tests whether or not grapefruit juice increases the absorbtion of rapamycin and what impact that may have on the cost and distribution of the Drug. Join...

Host: Sayantani DasGupta, MD, MPH Guest: Rita Charon, MD, PhD Narrative Medicine: a return to traditional clinical practice or a new way to care for patients? Host Dr. Sayantani DasGupta speaks with clinician and literary scholar Dr. Rita Charon, Founder and Director of the Program in Narrative Medicine at Columbia University, about the integration of medical humanities into traditional clinical p...

Host: Bill Rutenberg, MD Guest: Peter Bach, MD As former senior advisor to administration centers of Medicare and Medicaid Services for Cancer initiatives, our guest Dr. Peter Bach talks with host Bill Rutenberg about lessons learned while working on behalf of Medicare and Medicaid. Some highlights of this interview include discussion about physicians' use of evidence-based medicine, coverage unde...

Host: Bill Rutenberg, MD Guest: Peter Bach, MD We know that early detection of cancer can save lives. With this in mind, the focus turns to finding imaging mechanisms that will facilitate early detection. Does CT screening provide accurate information on lung cancer? Should high-risk patients undergo PET scans? Host Dr. Bill Rutenberg speaks with Dr. Peter Bach, of the Memorial Sloan Kettering Can...

Host: Bill Rutenberg, MD Guest: Peter Bach, MD Dr. Peter Bach, from the Memorial Sloan Kettering Cancer Center, talks with host Dr. Bill Rutenberg about racial disparities in medicine and treatment today. What are the reasons for this disparity, and how can we work to eliminate the difference? Join us to learn more.

Host: Bill Rutenberg, MD Guest: Peter Bach, MD What is keeping our society from moving forward in our ability to cure disease? How can what is learned in the lab be brought to the frontlines more quickly and efficiently? How can individual medical institutions work together to make a more profound difference in our healthcare system? Our Guest Dr. Peter Bach talks with host, Dr. Bill Rutenberg abo...

Host: Mark Nolan Hill, MD Guest: William Burke, MD Scientists at many institutions are researching to find neuroprotective agents for ALS. While today's guests research focuses on other neurological diseases, he recently wrote a commentary to a published neurology article about ALS research suggesting that the properties of a drug, Taxol should also be considered in animal models researching ALS....

Host: Mark Nolan Hill, MD Guest: William Burke, MD In this discussion, Dr. Hill learns from Dr. William Burke about the latest research trying to link the dopamine theory to the alpha synuclean theory to better explain why Parkinson's Disease occurs. In this segment they also discuss current symptomatic treatment for Parkinson's Disease and the properties that would make up a more curative neuropr...

Host: Mark Nolan Hill, MD Guest: Charles Morris Author and historian Charles Morris Morris “embedded” himself with the heart surgery team at New York's Columbia-Presbyterian Hospital to learn about the inner workings of a surgical heart center for his recent book, Surgeons: Life and Death in a Top Heart Center. In this segment, host Dr. Mark Nolan Hill talks with Mr. Morris about some of the more...

Host: Mark Nolan Hill, MD Guest: Charles Morris In this segment, host Dr. Mark Nolan Hill interviews historian and author Charles Morris about his recent book Surgery: Life and Death in a Top Heart Center. Charles shares in detail how the project got started, what he hoped to accomplish, what surprised him most and many interesting anecdotes about his experience.

Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA Guest: Ken Harbert, PhD Host Lisa D’Andrea, PA-C, talks with Ken Harbert, PhD, dean for the School of Physician Assistant Studies at South College in Knoxville, Tenn., about developing a physician assistant program. What makes it different from the medical degree (MD) and nurse practitioner (NP) education models.

Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA Guest: Ken Harbert, PhD Lisa D’Andrea talks with Dr. Ken Harbert a physician assistant and the president of Health Watch, a health care management firm that provides solutions for the utilization of Advanced Practice Clinicians. He is a Distinguished Fellow of the American Academy of Physician Assistants and serves on the board of directors of the America...

Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA Guest: Ken Harbert, PhD Lisa D'Andrea interviews Dr. Ken Harbert regarding the need for advanced practice clinicians as chief administrators in large health care systems.

Host: Lee Freedman, MD Guest: Aditya Bardia, MD Guest: Victor Montori, MD What is the efficacy of Vitamins and Antioxidants in cancer prevention? Dr. Aditya Bardia and Dr. Victor Montori, from the Mayo Clinic in Rochester, MN discuss a meta-analytical study designed to answer this question. Specifically covered are beta carotene, vitamin E, and selenium.

Host: Gary Kohn, MD Guest: Levi Garraway, MD, PhD Levi Garraway, MD, PhD, of the Dana Farber Cancer Institute in Boston, is credited with facilitating major advances in our understanding of cancer biology. He discusses the new paradigm of cancer, as a genomic disease which leads to abnormal activation of oncogenes and inactivation of suppressor genes. The implications for therapy, as we match gene...

Host: Gary Kohn, MD Guest: Levi Garraway, MD, PhD Levi Garraway, MD, PhD, recent recipient of the NIH Director’s New Innovator Award and assistant professor of medicine at the Harvard Medical School, has been credited with major advances in cancer biology. Dr. Garraway joins host Dr. Gary Kohn to discuss several common myths within our understanding of cancer biology and therapy.

Host: Gary Kohn, MD Guest: Suzanne Cannegieter Dr. Suzanne Cannegieter, Director of Clinical Epidemiology at Leiden University in the Netherlands, discusses her team's work with the international Wright Project focusing on connections between air travel and venous thrombosis.

Host: Gary Kohn, MD Guest: Suzanne Cannegieter Dr. Suzanne Cannegieter, director of clinical epidemiology, and the lead international researcher for the Wright Project, from Leiden University Medical Center in the Netherlands, talks about the history of research on deep venous thrombosis and extensive air travel.

Host: Larry Kaskel, MD Guest: Charles Potter, PhD Join Host Dr. Larry Kaskel interview Dr. Charlie Potter, CEO and inventor Glide Solid Dose Injector, WSJ innovative product runner up award winner in 2007. They will discuss the impact of a needle free delivery on distribution of immunizations, delivery of diabetic drugs and other exciting applications.

Host: Larry Kaskel, MD Guest: Charles Potter, PhD Needle-Free injection systems were being used to immunize large numbers of individuals after WWII. Did these needle-free systems, called ‘Jet Injectors’ actually work? If so, why has it taken us so long to develop a needle-free injection system that is a viable drug delivery tool today? Join host Dr. Larry Kaskel interviewing Charles Potter, CEO of...

Host: Shira Johnson, MD Guest: Benjamin Horne, PhD Guest: Brent Muhlestein, MD Dr Shira Johnson interviews Dr Benjamin Horne and Dr Brent Muhlestein from Intermountain Medical Center in Utah to discuss the practical implications of fasting on CV disease as studied in the Mormon population.

Host: Shira Johnson, MD Guest: Benjamin Horne, PhD Guest: Brent Muhlestein, MD Dr Benjamin Horne and Dr Brent Muhlestein from the Intermountain Medical Center in Utah discuss their recent research into the beneficial effects of fasting on cardiovascular risk.